Designated a breakthrough by the FDA when it was approved in late 2017, Foundation One CDx is one-stop shopping for gene based treatments.
Just one test can check for mutations in 324 genes involved in cancer growth, allowing oncologists to identify the most promising treatments quickly.
The FDA recently approved a similar test from Memorial Sloan Kettering Cancer Center in New York City; it’s called MSK-Impact, and it looks for mutations in 468 genes.
Source: AARP magazine October-November 2018
IF YOU LIKE THESE POSTS, PLEASE CONSIDER CLICKING THE DONATION BUTTON ABOVE. THANK YOU!